Bausch + Lomb announced today that it intends to bring its recently recalled enVista intraocular lenses (IOLs) back to the ...

Bausch + Lomb will return its enVista intraocular lenses to market following a voluntary recall in March after discovering they had certain production and material issues.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it has identified the event that led to its ...

Yes, a doctor can remove and replace an intraocular lens (IOL), a procedure known as an IOL exchange. However, this approach is rarely necessary. According to a 2023 retrospective study ...

Bausch + Lomb (NYSE:BLCO) shares gained on Thursday after the company announced plans to relaunch its intraocular lenses ...

Exclusive real-world insights on more than 9 million de-identified cataract surgery patients aims to advance clinical research, treatment optimization, and patient outcomesSAN FRANCISCO, April 24, ...

"Laser refractive surgery is not a one-size-fits-all solution. When a thorough eye evaluation is done to determine the right procedure for each individual, it offers excellent results with high ...

When cataract eye surgery is performed, the cloudy natural lens of the eye is removed, and a new intraocular lens, or IOL, is implanted to focus light properly and correct vision. The good news is ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized ...

Bausch + Lomb Corporation shares T.BLCO are trading up $0.79 at $18.37.

Staar Surgical ( ($STAA) ) just unveiled an update. On April 24, 2025, STAAR Surgical Company announced changes to its Board of Directors, ...

Laser refractive surgery offers a life-changing solution for those seeking to correct vision problems like myopia and ...